Oraichi D - Search Results

1

Prevalence and predictors of anti-infective use during pregnancy.

Santos F, Oraichi D, Bérard A. Santos F, et al. Among authors: oraichi d. Pharmacoepidemiol Drug Saf. 2010 Apr;19(4):418-27. doi: 10.1002/pds.1915. Pharmacoepidemiol Drug Saf. 2010. PMID: 20119971

2

Herbal products use during pregnancy: prevalence and predictors.

Moussally K, Oraichi D, Bérard A. Moussally K, et al. Among authors: oraichi d. Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):454-61. doi: 10.1002/pds.1731. Pharmacoepidemiol Drug Saf. 2009. PMID: 19326360 Review.

3

Health care providers' requests to Teratogen Information Services on medication use during pregnancy and lactation.

Gendron MP, Martin B, Oraichi D, Bérard A. Gendron MP, et al. Among authors: oraichi d. Eur J Clin Pharmacol. 2009 May;65(5):523-31. doi: 10.1007/s00228-008-0611-6. Epub 2009 Jan 24. Eur J Clin Pharmacol. 2009. PMID: 19169677

4

Antidepressant therapy during pregnancy: an insight on its potential healthcare costs.

Ramos E, Ofori B, Oraichi D, Bérard A. Ramos E, et al. Among authors: oraichi d. Can J Clin Pharmacol. 2008 Fall;15(3):e398-410. Epub 2008 Oct 24. Can J Clin Pharmacol. 2008. PMID: 18953084

5

Duration of antidepressant use during pregnancy and risk of major congenital malformations.

Ramos E, St-André M, Rey E, Oraichi D, Bérard A. Ramos E, et al. Among authors: oraichi d. Br J Psychiatry. 2008 May;192(5):344-50. doi: 10.1192/bjp.bp.107.042523. Br J Psychiatry. 2008. PMID: 18450657

6

Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective.

Bérard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D. Bérard A, et al. Among authors: oraichi d. Br J Clin Pharmacol. 2007 Feb;63(2):196-205. doi: 10.1111/j.1365-2125.2006.02837.x. Br J Clin Pharmacol. 2007. PMID: 17214828 Free PMC article.

7

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D. Bérard A, et al. Among authors: oraichi d. Birth Defects Res B Dev Reprod Toxicol. 2007 Feb;80(1):18-27. doi: 10.1002/bdrb.20099. Birth Defects Res B Dev Reprod Toxicol. 2007. PMID: 17187388

8

Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study.

Ofori B, Oraichi D, Blais L, Rey E, Bérard A. Ofori B, et al. Among authors: oraichi d. Birth Defects Res B Dev Reprod Toxicol. 2006 Aug;77(4):268-79. doi: 10.1002/bdrb.20085. Birth Defects Res B Dev Reprod Toxicol. 2006. PMID: 16929547

9

Inappropriate medication prescribing in community-dwelling elderly people living in Iran.

Azoulay L, Zargarzadeh A, Salahshouri Z, Oraichi D, Bérard A. Azoulay L, et al. Among authors: oraichi d. Eur J Clin Pharmacol. 2005 Dec;61(12):913-9. doi: 10.1007/s00228-005-0036-4. Epub 2005 Nov 24. Eur J Clin Pharmacol. 2005. PMID: 16307268

10

Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?

Azoulay L, Oraichi D, Bérard A. Azoulay L, et al. Among authors: oraichi d. Eur J Clin Pharmacol. 2006 Aug;62(8):667-74. doi: 10.1007/s00228-006-0151-x. Epub 2006 Jun 22. Eur J Clin Pharmacol. 2006. PMID: 16791584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results